IQCM Human Pre-designed siRNA Set A contains three designed siRNAs for IQCM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IQCN Human Pre-designed siRNA Set A contains three designed siRNAs for IQCN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IQGAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for IQGAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IQGAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for IQGAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IQGAP3 Human Pre-designed siRNA Set A contains three designed siRNAs for IQGAP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IQSEC1 Human Pre-designed siRNA Set A contains three designed siRNAs for IQSEC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IQSEC2 Human Pre-designed siRNA Set A contains three designed siRNAs for IQSEC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IQSEC3 Human Pre-designed siRNA Set A contains three designed siRNAs for IQSEC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IQUB Human Pre-designed siRNA Set A contains three designed siRNAs for IQUB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ir-CA is an antitumor agent. Ir-CA can accumulate in mitochondria and induces mitochondria dysfunction. Ir-CA induces apoptosis and autophagy. Ir-CA initiates mitophagy and cell cycle arrest to kill Cisplatin (HY-17394)-resistant A549R cells. Ir-CA can effectively inhibit metastasis by inhibiting MMP-2/MMP-9[1].

IRAG2 Human Pre-designed siRNA Set A contains three designed siRNAs for IRAG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRAK1 Human Pre-designed siRNA Set A contains three designed siRNAs for IRAK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Irak1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Irak1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Irak1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Irak1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRAK2 Human Pre-designed siRNA Set A contains three designed siRNAs for IRAK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRAK3 Human Pre-designed siRNA Set A contains three designed siRNAs for IRAK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRAK4 Human Pre-designed siRNA Set A contains three designed siRNAs for IRAK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRAK4 modulator-1 (example 161) is a modulator of IRAK4 with IC50=4.647 μM. IRAK4 modulator-1 can be used to study IRAK-mediated disorders[1].

Irak4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Irak4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Irak4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Irak4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Irbesartan-d7 is deuterated labeled Irbesartan (HY-B0202). Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic […]

Irbesartan-d7 hydrochloride is deuterated labeled Irbesartan hydrochloride (HY-B0202A). Irbesartan (SR-47436) hydrochloride is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan hydrochloride can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan hydrochloride can be used for the research of high blood […]

IREB2 Human Pre-designed siRNA Set A contains three designed siRNAs for IREB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF1 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF2 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF2BP1 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF2BP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF2BP2 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF2BP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF2BPL Human Pre-designed siRNA Set A contains three designed siRNAs for IRF2BPL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF3 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF4 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF5 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF6 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF7 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF8 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

IRF9 Human Pre-designed siRNA Set A contains three designed siRNAs for IRF9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Irganox 1330 (Ionox 330; Tris-BHT Mesitylene) is a phenolic antioxidant utilized in polymer processing[1].

Irganox 1330 (Ionox 330; Tris-BHT Mesitylene) is a phenolic antioxidant utilized in polymer processing[1].